Pembrolizumab monotherapy for the adjuvant treatment of renal cell carcinoma post-nephrectomy: Randomized, double-blind, Phase III KEYNOTE-564 study
Timasheva, Yu.,
Zudina, L.,
Balkhiyarova, Zh.,
Kaakinen, M.,
Munroe, P.,
Prokopenko, I.
Связанные документы (рекомендация CORE)